Evidence map›Paper›PMID 39621943›Full record

ArticleNano letters2024

The Role of Glycocalyx Diversity and Thickness for Nanoparticle Internalization in M1-/M2-like Macrophages.

Yu Liu, Yubei He, Han Xu, Amani Remmo, Frank Wiekhorst, Felix Heymann, Hanyang Liu, Eyk Schellenberger, Akvile Häckel, Ralf Hauptmann and 7 more

Abstract read
In one paragraph

Article in Nano letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Manuscript DMD-D-25-00346 The impact of glycocalyx on partitioning and distribution of basic drugs.Drug metabolism and disposition: the biological fate of chemicals · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yu LiuDepartment of Radiology, Campus Virchow-Klinikum (CVK), Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.ORCID 0009-0004-2581-1819
Yubei HeDepartment of Radiology, Campus Virchow-Klinikum (CVK), Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.
Han XuDepartment of Radiology, Campus Virchow-Klinikum (CVK), Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.
Amani RemmoPhysikalisch-Technische Bundesanstalt, Berlin 10587, Germany.ORCID 0000-0003-4171-5283
Frank WiekhorstPhysikalisch-Technische Bundesanstalt, Berlin 10587, Germany.
Felix HeymannDepartment of Hepatology, Campus Virchow-Klinikum (CVK), Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.
Hanyang LiuDepartment of Hepatology, Campus Virchow-Klinikum (CVK), Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.
Eyk SchellenbergerDepartment of Radiology, Campus Charité Mitte (CCM), Charité-Universitätsmedizin Berlin, Berlin 10117, Germany.
Akvile HäckelDepartment of Radiology, Campus Charité Mitte (CCM), Charité-Universitätsmedizin Berlin, Berlin 10117, Germany.
Ralf HauptmannDepartment of Radiology, Campus Charité Mitte (CCM), Charité-Universitätsmedizin Berlin, Berlin 10117, Germany.
Matthias TaupitzDepartment of Radiology, Campus Benjamin Franklin (CBF), Charité-Universitätsmedizin Berlin, Berlin 12203, Germany.
Yu ShenDeutsches Rheuma-Forschungszentrum (DRFZ), Berlin 10117, Germany.
Emine Yaren YilmazDepartment of Radiology, Campus Virchow-Klinikum (CVK), Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.
Dominik N MüllerExperimental and Clinical Research Center, a joint cooperation of Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin 13125, Germany.
Luisa HeidemannDepartment of Radiology, Campus Virchow-Klinikum (CVK), Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.
Robin SchmidtDepartment of Radiology, Campus Virchow-Klinikum (CVK), Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.ORCID 0000-0003-0012-2799
Lynn Jeanette SavicDepartment of Radiology, Campus Virchow-Klinikum (CVK), Charité-Universitätsmedizin Berlin, Berlin 13353, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Very small superparamagnetic iron oxide nanoparticles (VSOPs) show diagnostic value in multiple diseases as a promising MRI contrast agent. Macrophages predominantly ingest VSOPs, but the mechanism remains unclear. This study identifies differences in VSOP uptake between pro-inflammatory M1 and anti-inflammatory M2 macrophages and explores the role of the pericellular glycocalyx. Glycosaminoglycans (GAG) synthesis activities and the pericellular glycocalyx for M1/M2-like macrophages were assessed by RT-qPCR, Click-iT reaction, and WGA-FITC staining. The uptake of europium-VSOP and Synomag by the two subtypes was measured using Prussian blue staining, fluorescent microscopy, and magnetic particle spectroscopy. The findings revealed that M2-like macrophages had higher GAG synthesis activity, a thicker glycocalyx, and increased nanoparticle uptake compared to M1-like macrophages. Enzymatic glycocalyx degradation significantly decreased nanoparticle uptake. This study demonstrates a positive correlation between glycocalyx and nanoparticle uptake that could be exploited for imaging and targeted therapy, particularly in cancer, where macrophage subtypes play distinct roles.

Indexed as

GlycocalyxMacrophagesAnimalsContrast MediaGlycosaminoglycansHumansMagnetic Iron Oxide NanoparticlesMagnetic Resonance ImagingMiceRAW 264.7 CellsContrast MediaGlycosaminoglycansglycocalyxM1/M2 macrophagesnanoparticles uptakeSPIONVSOP

Identifiers

PMID39621943
PMCPMC11638944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.